GlassScriptPhysician profile
Amanda Leigh Harrup
NPI 1558972166
$5,399.10
in general payments reported to CMS, 2019-2025
37 companies · $897 in 2025
The $897 reported for 2025 was more than what 81% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11.33 · 2022: $995 · 2023: $2,185 · 2024: $1,311 · 2025: $897.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,392.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,392.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $843.35 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $743.42 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Pfizer INC. | $540.49 | 2022-2025 | |
| Lilly USA, LLC | $469.67 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $372.24 | 2023-2025 | |
| Amgen INC. | $290.42 | 2023-2024 | Repatha, Otezla, Prolia |
| Astrazeneca Pharmaceuticals LP | $248.08 | 2023-2025 | Fasenra, Airsupra, Breztri |
| Bayer Healthcare Pharmaceuticals INC. | $193.81 | 2021-2025 | |
| Dexcom, INC. | $166.89 | 2022-2025 | Dexcom G6 Transmitter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $152.21 | 2022-2025 | Xifaxan |
| Xeris Pharmaceuticals, INC. | $135.93 | 2023-2025 | Gvoke Hypopen |
| Astellas Pharma US INC | $120.34 | 2023 | Veozah, Myrbetriq |
| Novartis Pharmaceuticals Corporation | $109.55 | 2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $102.84 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $98.66 | 2022-2025 | Ofev, Jardiance |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Harrup listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.